Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bicara Therapeutics Inc. | 897,587 | reported | 17 Sept 2024 | tx 6+1,795,174−15,946,650 |
| PepGen Inc. | 476,813 | reported | 10 May 2022 | tx 6+953,626−546,626 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 862,587 | — | |
| 17 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 862,587 | — | |
| 17 Sept 2024 | PURCHASE | Bicara Therapeutics Inc. | 35,000 | 18.00 USD | first after silence |
| 17 Sept 2024 | PURCHASE | Bicara Therapeutics Inc. | 35,000 | 18.00 USD | |
| 17 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 7,973,325 | — | deriv |
| 17 Sept 2024 | CONVERSION | Bicara Therapeutics Inc. | 7,973,325 | — | deriv |
| 10 May 2022 | CONVERSION | PepGen Inc. | 268,480 | — | |
| 10 May 2022 | CONVERSION | PepGen Inc. | 268,480 | — | |
| 10 May 2022 | PURCHASE | PepGen Inc. | 208,333 | 12.00 USD | |
| 10 May 2022 | PURCHASE | PepGen Inc. | 208,333 | 12.00 USD | |
| 10 May 2022 | CONVERSION | PepGen Inc. | 273,313 | — | deriv |
| 10 May 2022 | CONVERSION | PepGen Inc. | 273,313 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 17 Sept 2024.